TCR2 Therapeutics

+$0.19 (+1.48%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRR and other ETFs, options, and stocks.

About TCRR

TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It also involves in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development.

CEO

Garry E. Menzel

Employees

118

Headquarters

Cambridge, Massachusetts

Founded

2015

TCRR Key Statistics

Market Cap

750.46M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

333.34K

High Today

$13.06

Low Today

$12.47

Open Price

$12.94

Volume

222.91K

52 Week High

$35.86

52 Week Low

$12.15

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

TCRR Earnings

-$0.67

-$0.45

-$0.22

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 11, Pre-Market